Sophie V. Vandebroek
At a glance: Sophie V. Vandebroek is Director at Idexx Laboratories (IDXX). Their latest SEC Form 4, filed Feb 19, 2026, reported a sale of $594K. On file: 0 purchase lines ($0) and 2 sale lines ($920K).
Disclosed holdings: about $448K of IDXX stock: 648 shares reported on their latest Form 4 (filed Feb 19, 2026), valued at the Nov 19, 2026 close of $690.95. This counts only IDXX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Idexx Laboratories Inc /De (IDXX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Sophie V. Vandebroek's InsiderPrint
2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 19SEC | IDXXIdexx Laboratories Inc /De | Sell | 9451,167 held (−45%) | $628.65 | $594K | +9.9% |
| Feb 19SEC | IDXXIdexx Laboratories Inc /De | Sell | 519648 held (−44%) | $628.56 | $326K | +9.9% |
- Sell
Director Sophie V. Vandebroek sold $594K of IDXX at $628.65 — cuts the stake by 45%.
- Sell
Director Sophie V. Vandebroek sold $326K of IDXX at $628.56 — cuts the stake by 44%.
Follow Sophie V. Vandebroek
Get one email when Sophie V. Vandebroek files a new purchase or sale. Free.
At most one email a day about Sophie V. Vandebroek, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.